Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.

Institute Director

Your Contribution

The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.

Institute Director

Your Contribution

EDENT1FI

EDENT1FI is a global consortium comprised of 28 partners spanning 12 countries. These partners have come together with a shared mission: to identify T1D at its pre-clinical stage in children in the general population. The project is funded through the Horizon Europe program and is set to run over five years.

EDENT1FI website

Press release

European pre-T1D Registry

European pre-T1D Registry is a network of investigators who register children and adults diagnosed with early-stage type 1 diabetes to inform about monitoring, trials, and treatment to delay or prevent disease progression. European pre-T1D Registry is operated by Helmholtz Munich under the umbrella of GPPAD & INNODIA.

pre-T1D Registry website

pre-T1D Registry dashboard

K1DS ARE HEROES

The K1DS ARE HEROES campaign spots type 1 diabetes heroes around the world! The campaign aims to raise awareness for type 1 diabetes, early detection and prevention of type 1 diabetes. The campaign is run by GPPAD together with the Institute of Diabetes Research (IDF) at Helmholtz Munich.

Doctor drawing man's blood sample in clinic, closeup AdobeStock_1937412501

A population-based cohort study provides new data on the prevalence of early-stage type 1 diabetes in young adults, addressing a gap in epidemiological research. Using samples from the LISA and GINIplus cohorts and methodologies established in the…

EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an…

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

First results of the Primary Oral Insulin Trial (POInT) mark an important step towards the prevention of type 1 diabetes, pointing future efforts to personalized strategies. The group led by researchers from Helmholtz Munich and the Technical…

Children with a family history of type 1 diabetes (T1D) have an increased risk of developing the disease. However, children born to mothers with T1D are less likely to develop the disease than those whose fathers or siblings have T1D. A new study…

Warncke, K., Weiss, A., Achenbach, P., von dem Berge, T., Berner, R., Casteels, K., Groele, L., Hatzikotoulas, K., Hommel, A., Kordonouri, O., Elding Larsson, H., Lundgren, M., Marcus, B. A., Snape, M. D., Szypowska, A., Todd, J. A., Bonifacio, E., Ziegler, A. G., & GPPAD and POInT Study Groups

Elevations in blood glucose before and after the appearance of islet autoantibodies in children.

Ziegler, A.-G. ; Kick, K. ; Bonifacio, E. ; Haupt, F. ; Hippich, M. ; Dunstheimer, D. ; Lang, M. ; Laub, O. ; ... ; Assfalg, R. ; Jolink, M. ; Winkler, C. ; Achenbach, P.

Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany.

Hippich, M. ; Beyerlein, A. ; Hagopian, W.A. ; Krischer, J.P. ; Vehik, K. ; Knoop, J. ; Winker, C. ; ... ; Ziegler, A.-G. ; The Teddy Study Group

Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families.

Anette G. Ziegler, MD; Marian Rewers, MD, PhD; Olli Simell, MD, PhD; Tuula Simell, MPH, PhD; Johanna Lempainen, MD, PhD; Andrea Steck, MD; Christiane Winkler, PhD; Jorma Ilonen, MD, PhD; Riitta Veijola, MD, PhD; Mikael Knip, MD, PhD; Ezio Bonifacio, PhD; George S. Eisenbarth, MD, PhD

Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children.

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler

Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)

Heidemannstraße 1, 80939 München

Telephone: +49 89 3187 2896
E-mail: anettegabriele.zieglerspam prevention@helmholtz-munich.de

On This Page

Research Platforms

EDENT1FI

European pre-T1D Registry

Campaigns

K1DS ARE HEROES

Rethinking Early Detection: Type 1 Diabetes in Young Adults

100,000 Participants Screened for Early-Stage Type 1 Diabetes in the EDENT1FI Project

Helmholtz Munich Secures Funding to Investigate Early-Stage Type 1 Diabetes in Adults

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

New Milestone Towards Personalized Prevention of Type 1 Diabetes

Maternal Type 1 Diabetes May Protect Children Through Epigenetic Changes

Univ.-Prof. Dr. med. Anette-Gabriele Ziegler